Page 226 - Pharmaceutics IV (02-06-01305)
P. 226

30/03/2024

    • The	nasal	route	has	some	obstacles	to	
      achieve	effective	treatment	due	to	the	
      unpredictable	absorption	after	application.

    • Before	considering	the	bioavailability	of	the	
      drugs	loaded	in	nanoparticles,	in	vivo	and	in	
      vitro	evaluation	tests	should	be	performed.	

    Dr ALyaa Ramadan, AU         27

27

    Formulation
                    Development

    Dr ALyaa Ramadan, AU         28

28

                                                      14
   221   222   223   224   225   226   227   228   229   230   231